O r i g i n a l A r tic le
I NTRO D U C TIO N
Of all endoscopic procedures, bronchoscopy without sedation might be one of the most painful and uncomfortable experiences. Therefore, unless absolute contraindications exist, sedation or anaesthesia is recommended for patients undergoing bronchoscopy.
(1) As bronchoscopists and anaesthesiologists have to share the same airway tract, the challenge of performing bronchoscopy and maintaining normal oxygen saturation (SpO 2 ), while suppressing the high sympathetic response to airway stimulation, is great. Moderate sedation (MS), also known as conscious sedation, via the use of a combination of benzodiazepine and opiates is the most commonly used regimen during fibre-optic bronchoscopy. (2) (3) (4) MS is achieved with a druginduced depression of consciousness, during which patients respond purposefully to verbal commands, either alone or accompanied by light tactile stimulation. (5) In MS, no intervention is required to maintain a patent airway, spontaneous ventilation is adequate, and cardiovascular function is usually maintained.
Recently, propofol has proven effective during bronchoscopy, achieving similar results as the combined administration of midazolam and opiates in aspects such as sedation, amnesia and patient tolerance. (6) Moreover, propofol has the advantage of a shorter recovery time. (7) (8) The widely used combination of either midazolam or propofol and opiates to achieve MS for bronchoscopy has been known to result in a high incidence (~30%-50%) of hypoxaemia (i.e. SpO 2 < 90%) and a relatively high cough score. (9 -11) However, the use of high frequency jet ventilation (HFJV) can provide adequate gas exchange, thus avoiding hypoxaemia without interfering with the manoeuvre of the bronchoscopist.
HFJV has been successfully applied in rigid bronchoscopy and difficult airway intubation. (12) (13) (14) In light of this, the combination of general anaesthesia (GA) with HFJV might be a more acceptable regimen than conventional MS in bronchoscopy, especially with the former's lower incidence of hypoxaemia and lower cough score. To the best of our knowledge, there has been no published randomised controlled study comparing MS with GA achieved via target-controlled infusion (TCI) of propofol and remifentanil with HFJV, with respect to the incidence of oxygen desaturation, haemodynamic parameters, cough score, duration of bronchoscopy and patient satisfaction. Efficacy of target-controlled infusion of propofol and remifentanil with high frequency jet ventilation in fibre-optic bronchoscopy INTRODUCTION Sedation or anaesthesia is recommended for all patients undergoing bronchoscopy unless absolute contraindications exist. However, the widely used combination of propofol and opiates for moderate sedation (MS) in bronchoscopy results in a high incidence of hypoxaemia and a relatively high cough score during the procedure. In this study, we evaluated the efficacy and safety of target-controlled infusion (TCI) of propofol and remifentanil, together with the use of high frequency jet ventilation (HFJV), to achieve general anesthesia (GA) in diagnostic fibre-optic bronchoscopy.
M E TH O DS
METHODS A total of 92 consecutive patients scheduled for flexible bronchoscopy were randomly assigned to receive either MS using TCI-delivered propofol and remifentanil (n = 46), or GA using TCI-delivered propofol and remifentanil with HFJV (n = 46). The following were compared between the MS and GA groups: incidence of hypoxaemia, cough score, haemodynamic parameters, partial pressure of carbon dioxide in arterial blood, duration of bronchoscopy and patient satisfaction score.
all patients included in this study. All patients fasted for six hours without premedication prior to the procedure. In the preparation room, a peripheral venous line was established to administer 250 mL of Ringer's solution for a period of 20 mins before bronchoscopy. A catheter was also inserted into the radial artery to enable instant monitoring of haemodynamic changes and collect arterial blood samples to determine blood gases. Supplemental oxygen at 4 L/min was administered through a nasal cannula before sedation. In this study, all bronchoscopies were conducted by the same team, which included two nurses, one bronchoscopist, and one anaesthesiologist specialising in bronchoscopic anaesthesia and sedation. MS and GA were administered by the anaesthesiologist.
Topical anaesthesia was administered to all the patients in both the MS and GA groups prior to bronchoscopy by spraying the nostril, nasopharynx and oropharynx with 3 mL of 2%
lidocaine. An additional 3 mL of 2% lidocaine was applied to the tracheobronchial tree in a spray-as-you-go manner during the procedure. In the MS group, oxygen was administered at 4 L/min via a nasal cannula throughout the bronchoscopy.
Propofol was administered at a plasma target concentration of 1.5 μg/mL using a TCI pump (Graseby 3500, Smiths Medical, If the patient's heart rate (HR) was < 50 bpm and/or systolic blood pressure < 85 mmHg, 1 mg of dopamine was administered intravenously. In this study, tachycardia was defined as HR > 100 bpm, and hypertension was defined as The incidence of hypoxaemia in patients who underwent fibre-optic bronchoscopy with MS has been reported to be ~30%-50%. (9 -11) In patients who underwent the same procedure but with GA, this incidence is assumed to be 10%. A p-value of < 0.05 was considered significant.
RESUlTS
Patient characteristics and action taken during bronchoscopy are shown in Table I . The most common actions taken during bronchoscopy were inspection, and inspection and lavage, followed by inspection, lavage and endobronchial biopsy.
Data pertaining to the incidence and degree of hypoxaemia experienced during bronchoscopy are shown in Table II .
Two patients in the MS group were excluded from analysis pertaining to hypoxaemia because the bronchial artery was injured (emergency surgery was carried out for these two patients). We found the incidence of hypoxaemia in the GA D at a is p re s e nte d a s m e a n ± s t a n da rd d ev iatio n . * B lo o d g a s analysis of blood samples taken from two patients in the MS group failed to detect PaCO 2 . Another two patients were excluded from PaCO 2 analysis because the bronchial artery was injured. GA: general anaesthesia; MS: moderate sedation; T0: before sedation; T1: 5 mins after the star t of bronchoscopy; T2: immediately after bronchoscopy; T3: 5 mins after bronchoscopy group to be significantly lower than that in the MS group. No significant difference in the baseline SpO 2 values between the two groups was observed. However, both the average and minimum SpO 2 values in the MS group were lower than that in the GA group.
PaCO 2 obtained via blood gas analysis are shown in Table III . Blood gas analysis of blood samples taken from two patients in the MS group failed to detect PaCO 2 , as the blood gas analyser could not analyse the two blood samples.
No significant difference in PaCO 2 values between the two groups (at different time points in the procedure) was found.
Haemodynamic parameters are shown in Table IV . The incidences of hypertension and tachycardia in the GA group were 1 and 2, respectively, when recorded at the time the carina was reached. These were significantly lower than the incidences of hypertension and tachycardia (8 and 14, respectively) recorded in the MS group at the same time. HR values in the MS group at the time the carina was reached were significantly increased when compared to those at baseline. Table V compares the outcome parameters between the MS and GA groups. Cough score and the duration of bronchoscopy were markedly lower in the GA group; patient satisfaction score and the number of patients willing to repeat the procedure were higher in the GA group than the MS group.
The doses of propofol and remifentanil used were higher in the GA group. There was no significant difference in the number of patients needing dopamine between the two groups. The mean time taken to regain consciousness in the GA group was 3.7 ± 1.6 mins.
D I SCU S S IO N
Our results demonstrate that a regimen of GA achieved using TCI-delivered propofol and remifentanil, together with HFJV, could dramatically decrease the incidence of hypoxaemia in fibre-optic bronchoscopy. Moreover, the results of our study also show that GA, when compared against MS, could provide better conditions for bronchoscopy by lowering cough score and creating a more stable haemodynamic profile through effective suppression of the sympathetic response.
The advantage of using opiates in bronchoscopy is their antitussive properties. (2) The use of propofol (with or without opiates; administered intravenously via intermittent bolus or patient-controlled analgesia pump) for MS in bronchoscopy has been increasingly reported. (6, 9, 16) In this study, we administered propofol and remifentanil using TCI. These two intravenous medications are optimal for delivery via TCI because of their short context-sensitive half-lives. (17) When administered with a plasma target model, TCI could lead to more stable haemodynamic parameters. (18) Currently, most patients undergoing bronchoscopy receive MS with a different regimen than the one used in the present study. (2) It is difficult for anaesthesiologists and bronchoscopists to find a balance between MS and sufficient oxygenation due to individual differences among patients.
Even when combined with topical anaesthesia, many patients who are awake during the procedure inevitably experience discomfort, severe cough, dramatic haemodynamic change and hypoxaemia. Both tachycardia and myocardial ischaemia are also frequently present in elderly patients who undergo MS during bronchoscopy. (10) Given these concerns, we compared the MS (set as the control group) and GA groups.
GA was achieved using TCI-delivered propofol and remifentanil, together with HFJV, in an attempt to maintain patient amnesia and more effectively suppress the airway reflex during bronchoscopy. The GA regimen was initiated with 4.0 μg/mL of propofol and 4.0 ng/mL of remifentanil, both delivered via TCI using a plasma target model. When the bronchoscope reached the carina, the target plasma concentrations of propofol and remifentanil were decreased Data is presented as mean ± standard deviation. *Two patients were excluded because the bronchial artery was injured, and data for MAP and HR could not be obtained. †p < 0.01, as compared to T0.
GA: general anaesthesia; HR: heart rate; MAP: mean arterial pressure; MS: moderate sedation; T0: before sedation; T1: immediately before bronchoscopy; T2: at the time the carina was reached; T3: 5 mins after bronchoscopy Table V demonstrated that the ED95 of the effective-site concentration of propofol at loss of consciousness is 2.0 ± 0.9 μg/mL. (19) In addition, the concentration of remifentanil was adjusted based on the clinical need to suppress airway stimulation reflex. Remifentanil is an effective antitussive medication with an ultra-short t 1/2 k e0 , which makes it possible to achieve the desired effect site concentration instantly. (20) Our results indicate that patients in the GA group (i.e. those who received TCI-delivered propofol and remifentanil together with HFJV) demonstrated a lower cough score and a higher satisfaction score. The GA group also had a shorter procedural duration than the MS group and a greater number of patients willing to repeat the procedure. These benefits may be attributable to the inherent characteristics of GA, in which strong airway stimulation is suppressed and patients remain amnesiac during the entire bronchoscopy. Our results also indicate that HR values in the MS group at the time the carina was reached were significantly increased compared to those at baseline. Only one patient in the GA group required the administration of dopamine; that patient's blood pressure rapidly returned to normal after dopamine was administered.
The incidences of hypertension and tachycardia in the GA group were 1 and 2, respectively, when recorded at the time the carina was reached. These were significantly lower than the incidences of hypertension and tachycardia Hypoxaemia is the most common complication during bronchoscopy when using MS or topical anaesthesia alone.
Our data showed that the incidence of hypoxaemia in the MS group was consistent with previous documentations of SpO 2 < 90% in 30%-50% of patients undergoing fibre-optic bronchoscopy with MS regimens. (9 -11) Factors contributing to hypoxaemia during bronchoscopy with sedation include respiratory depression or upper airway obstruction due to excessive sedation, reflex bronchoconstriction in response to bronchoscopy or lavage (often due to inadequate sedation), persistent coughing, or endotracheal suction. (7) To address these problems, we introduced the use of HFJV and TCI-delivered intravenous propofol and remifentanil in the GA group. The feasibility of HFJV in bronchoscopy, and in cases of difficult airway management, has been reported. HFJV is usually administered using a specially devised adaptor via a laryngeal mask airway, (12) together with a bronchoscope (which forms the shared channel between the jet injection and suction), (21) or delivered through a thin nylon catheter. (22) Even though HFJV delivery takes the same route as the suction, HFJV can be interrupted when lavage or suction is needed.
Similarly, an unanchored nylon catheter placed in the trachea could be accidentally pulled out during bronchoscopy, which might lead to a risk of gastrointestinal insufflation. (23) To avoid these problems, we used a 2-mm diameter nylon catheter that had its tip bound 8 cm from the end of the bronchoscope.
HFJV was initiated when the bronchoscope reached the carina, and discontinued when the tip of the bronchoscope was withdrawn above the carina. Thus, we could ensure that the tip of the catheter remained in the trachea and the lungs could be ventilated effectively. Our data demonstrates that the patients in the GA group presented a dramatically lower incidence of hypoxaemia (2.2%) than those in the MS group (34.1%). Only one patient in the GA group had SpO 2 < 90%, which had resulted from bronchial spasm and coughing due to inadequate sedation. In that case, the concentration of remifentanil was immediately increased and SpO 2 quickly returned to normal.
Blood gas analysis revealed normal PaCO 2 for both the GA and MS groups. Although our finding is consistent with other studies, (12, 21) Hautmann et al reported an increase in PaCO 2 in patients receiving HFJV in interventional fibre-optic bronchoscopy, with two cases exceeding 80 mmHg. 
In the present study, GA, induced by TCI-delivered propofol and remifentanil together with HFJV, showed marked benefits in diagnostic bronchoscopy. However, our study had limitations. Firstly, patients requiring interventional procedures or those with an ASA status of Class IV and above were not included in our study. Secondly, our study was not blinded due to practical reasons. We propose that future studies be blinded and include prolonged interventional bronchoscopy.
In conclusion, GA achieved via TCI-delivered propofol and remifentanil, coupled with HFJV, is a simple and safe regimen in diagnostic bronchoscopy. This GA regimen provides better conditions for diagnostic bronchoscopy -it decreases the occurrence of hypoxaemia, shortens the duration of bronchoscopy and increases patient comfort.
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